Real-World EV Plus Pembro Success Seen in Urothelial Cancer

admin · 发表于昨天 20:09

马上注册，阅读更多内容，享用更多功能！

您需要登录才可以下载或查看，没有账号？立即注册

×

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.
Medscape Medical News

账号		自动登录	找回密码
密码			立即注册